These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24412596)

  • 41. ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.
    Kunkl M; Porciello N; Mastrogiovanni M; Capuano C; Lucantoni F; Moretti C; Persson JL; Galandrini R; Buzzetti R; Tuosto L
    Front Immunol; 2017; 8():502. PubMed ID: 28491063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.
    Chapman A; Stewart SJ; Nepom GT; Green WF; Crowe D; Thomas JW; Miller GG
    J Immunol; 1996 Dec; 157(11):4771-80. PubMed ID: 8943378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-->S phase transitions at an optimal rate.
    Bonnevier JL; Yarke CA; Mueller DL
    Eur J Immunol; 2006 Jun; 36(6):1583-97. PubMed ID: 16703564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.
    Sweeney ME; Slusser JG; Lynch SG; Benedict SH; Garcia SL; Rues L; LeVine SM
    Int Immunopharmacol; 2011 Nov; 11(11):1796-801. PubMed ID: 21807124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation.
    Yokosuka T; Kobayashi W; Sakata-Sogawa K; Takamatsu M; Hashimoto-Tane A; Dustin ML; Tokunaga M; Saito T
    Immunity; 2008 Oct; 29(4):589-601. PubMed ID: 18848472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.
    Duszczyszyn DA; Beck JD; Antel J; Bar-Or A; Lapierre Y; Gadag V; Haegert DG
    Clin Exp Immunol; 2006 Feb; 143(2):305-13. PubMed ID: 16412055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
    Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
    Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase.
    Truitt KE; Shi J; Gibson S; Segal LG; Mills GB; Imboden JB
    J Immunol; 1995 Nov; 155(10):4702-10. PubMed ID: 7594470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.
    Wells AD; Gudmundsdottir H; Turka LA
    J Clin Invest; 1997 Dec; 100(12):3173-83. PubMed ID: 9399965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
    Crome SQ; Wang AY; Kang CY; Levings MK
    Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
    Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
    Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation.
    Aune TM; Mora AL; Kim S; Boothby M; Lichtman AH
    J Immunol; 1999 May; 162(10):5805-12. PubMed ID: 10229814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
    Beyersdorf N; Balbach K; Hünig T; Kerkau T
    Immunology; 2006 Dec; 119(4):441-50. PubMed ID: 16903867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T Cell Receptor-Independent, CD31/IL-17A-Driven Inflammatory Axis Shapes Synovitis in Juvenile Idiopathic Arthritis.
    Ferguson ID; Griffin P; Michel JJ; Yano H; Gaffen SL; Mueller RG; Dvergsten JA; Piganelli JD; Rosenkranz ME; Kietz DA; Vallejo AN
    Front Immunol; 2018; 9():1802. PubMed ID: 30127787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
    Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
    J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation.
    Harada Y; Tanabe E; Watanabe R; Weiss BD; Matsumoto A; Ariga H; Koiwai O; Fukui Y; Kubo M; June CH; Abe R
    J Biol Chem; 2001 Mar; 276(12):9003-8. PubMed ID: 11113113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The T-cell pool is anergized in patients with multiple sclerosis in remission.
    Fransson ME; Liljenfeldt LS; Fagius J; Tötterman TH; Loskog AS
    Immunology; 2009 Jan; 126(1):92-101. PubMed ID: 18624727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.